|Message:||Recipients' Email:||Type address separated by commas|
|Your Email:||Enter the characters shown in the image.|
|Send me a copy:|
The Chinese crisis and India scouting for alternative sources of pharmaceutical bulk drugs has come as a shot in the arm for sick public sector enterprise Hindustan Antibiotics Ltd (HAL). The company is charting a turnaround plan by starting to manufacture the key bulk drugs that the government has identified under a production linked incentive (PLI) scheme.
Speaking to Business ...
Read the full text business-standard